NOL3 and myalgic encephalomeyelitis/chronic fatigue syndrome: In the future, it will be necessary to study the neurobiological mechanisms through analysis of biologically active substances of MYP components and changes in other neurotransmitters in relation to the improvement of ME/CFS symptoms.